Cargando…
Molecular Mechanisms of Mesenchymal Stem Cell-Based Therapy in Acute Kidney Injury
Acute kidney injury (AKI) causes a lot of harm to human health but is treated by only supportive therapy in most cases. Recent evidence shows that mesenchymal stem cells (MSCs) benefit kidney regeneration through releasing paracrine factors and extracellular vesicles (EVs) to the recipient kidney ce...
Autores principales: | Lee, Pei-Wen, Wu, Bo-Sheng, Yang, Chih-Yu, Lee, Oscar Kuang-Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583897/ https://www.ncbi.nlm.nih.gov/pubmed/34768837 http://dx.doi.org/10.3390/ijms222111406 |
Ejemplares similares
-
Additional benefit of induced pluripotent stem cell-derived mesenchymal stem cell therapy on sepsis syndrome-associated acute kidney injury in rat treated with antibiotic
por: Yang, Chih-Chao, et al.
Publicado: (2021) -
Adipose-derived mesenchymal stem cells attenuate dialysis-induced peritoneal fibrosis by modulating macrophage polarization via interleukin-6
por: Yang, Chih-Yu, et al.
Publicado: (2021) -
Mesenchymal stem cell therapy targeting mitochondrial dysfunction in acute kidney injury
por: Zhao, Lingfei, et al.
Publicado: (2019) -
Optimization strategies of mesenchymal stem cell-based therapy for acute kidney injury
por: Fu, Zhangning, et al.
Publicado: (2023) -
Prediction of the development of acute kidney injury following cardiac surgery by machine learning
por: Tseng, Po-Yu, et al.
Publicado: (2020)